SOURCE: Equity News Circuit

Equity News Circuit

January 16, 2013 08:45 ET

Free Research Reports on RSYS, SNTS, VPHM and VRTX Issued by the Bedford Report

Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT

NEW YORK, NY--(Marketwire - Jan 16, 2013) - The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

RadiSys Corporation (NASDAQ: RSYS) shares gained as much as 20 percent in trading Tuesday after reporting it expects to turn a profit in the fourth quarter. The company expects revenues to be at the high end of their previous guidance.

Find out more about RadiSys including full access to the free equity report at:

Santarus, Inc. (NASDAQ: SNTS) shares soared over 10 percent on nearly five-times the average daily volume Tuesday. The biotech company reported that the FDA has approved UCERIS, a treatment for chronic inflammatory bowel disease.

Find out more about Santarus including full access to the free equity report at:

Viropharma Inc. (NASDAQ: VPHM) shares gained 8 percent on over 2 million shares traded Tuesday. Bank of America Merrill Lynch recently upgraded the company's rating to "buy" from hold" and raised its 2013 projections for Cinryze.

Find out more about Viropharma including full access to the free equity report at:

Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) shares fell sharply in early morning trading Tuesday after analysts at Lazard Capital cut the company's rating to "neutral". The firm believes 2013 will be a "transition year" for the company.

Find out more about Vertex Pharmaceuticals including full access to the free equity report at:

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein.

A third party, Providence Media Strategies LLC has paid Equity News Circuit four hundred and fifty dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information